Core Concepts of Bioavailability

Overview of Bioavailability Introduction Bioavailability is one of the most important concepts in pharmacology and nutrition science. It describes how much of an administered dose actually reaches your systemic circulation (bloodstream) where it can exert its effects. Understanding bioavailability is essential for predicting drug efficacy, determining appropriate doses, and comparing different formulations or routes of administration. What is Bioavailability? Bioavailability is defined as the fraction of an administered dose that reaches the systemic circulation. This fraction is expressed either as a decimal value ($f$, ranging from 0 to 1) or as a percentage ($F$, ranging from 0 to 100%). The Intravenous Standard Intravenous (IV) administration is considered the gold standard with 100% bioavailability (or $f = 1.0$). This is because the drug is placed directly into the bloodstream, bypassing all absorption barriers. Why Non-Intravenous Routes Have Lower Bioavailability Any route of administration that doesn't bypass the gastrointestinal tract—such as oral (PO), intramuscular (IM), or transdermal routes—results in lower bioavailability. Two main factors cause this reduction: Absorption barriers: The intestinal epithelium acts as a selective barrier that may prevent complete absorption of the drug. First-pass metabolism: When drugs are absorbed from the gastrointestinal tract, they travel through the hepatic portal system directly to the liver before reaching the systemic circulation. The liver metabolizes some of the drug, reducing the amount that reaches the bloodstream. For example, a drug with oral bioavailability of 0.40 means that only 40% of an orally administered dose reaches the systemic circulation; the remaining 60% is either not absorbed or is metabolized during first-pass. How Bioavailability is Calculated Bioavailability is determined by comparing the area under the plasma concentration-time curve (AUC) of a non-intravenous formulation to the AUC of the intravenous formulation. Understanding the AUC The area under the curve (AUC) is directly proportional to the total amount of drug that enters the systemic circulation. When you plot plasma drug concentration over time, the area beneath the curve mathematically represents the total drug exposure. The image above shows this concept: the red-shaded area represents the AUC after IV administration (which is rapid and complete), while the blue-shaded area represents the AUC after oral administration (which is slower but still results in meaningful drug exposure). The Bioavailability Equation Bioavailability is calculated using: $$f = \frac{\text{AUC}{\text{non-IV}}}{\text{AUC}{\text{IV}}}$$ For example, if the AUC after an oral dose is half the AUC after an IV dose of the same amount, the oral bioavailability is 0.5 (or 50%). This comparison can be made for any two different routes of administration, not just IV versus non-IV. Population Variability and Practical Dosing Implications Bioavailability Values are Averages The bioavailability values you see reported in literature (e.g., "oral bioavailability = 60%") are population averages obtained from clinical studies. However, there is always significant variability between individuals. This variability is expressed as a deviation range, such as "60% ± 20%." This notation tells you that: The average bioavailability is 60% Individual values typically range from 40% to 80% Why Variability Matters for Dosing Understanding this variability is clinically important. When determining doses, healthcare providers often use the lower limit of the bioavailability range to ensure that even patients with poor absorption receive adequate drug exposure. This is especially critical for drugs with a narrow therapeutic window—a small range between the minimum effective dose and the maximum tolerated dose. Drugs in this category (such as warfarin for anticoagulation or digoxin for heart failure) require careful dose adjustment because too little is ineffective and too much is toxic. Example: If a drug has reported bioavailability of 50% ± 15%, the range is 35% to 65%. A prescriber might base dosing decisions on the 35% figure to ensure that even a patient in the lower range of absorption receives sufficient drug. Bioavailability of Nutrients and Dietary Supplements Different Definition for Non-Drugs For dietary supplements, herbs, and nutrients, the definition of bioavailability is slightly different: it refers to the fraction of the ingested dose that is absorbed, regardless of whether it reaches systemic circulation. This is because many nutrients work through local effects in the gastrointestinal tract or have different biological roles than pharmaceutical drugs. Greater Variability in Nutrient Bioavailability Nutrient bioavailability depends heavily on the individual's nutritional status and physiological condition, leading to much greater inter-individual variation than is typically seen with drugs. Factors that influence nutrient bioavailability include: Current nutrient stores in the body (someone deficient in iron will absorb iron more efficiently than someone with adequate iron stores) Digestive health and stomach acid production Presence of other foods or compounds that enhance or inhibit absorption Genetic factors affecting absorption mechanisms Age and metabolic status This is why nutrition recommendations often need to be more personalized than pharmaceutical dosing guidelines.